शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
RAINBOWNSERainbow Childrens Medicare Limited· Healthcare ServicesHighNeutral
Announced Thu, 13 Nov, 2025 · 17:42 IST

Rainbow Childrens Q2 FY26 PAT Rs 756M; revenue up 6.5% YoY

RAINBOW · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹1353.40
prior close
₹1353.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%-1.3% vs market
Hospital peers, median of 19sector+0.3%-1.4% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Smallcap 250 and 1.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.8
10m
-1.5
15m
-1.5
30m
-1.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1+0.2-1.3+0.3-1.4
Next day
-3.6+0.9-4.4+0.6-4.1
2d
-3.9-0.2-3.7-0.3-3.6
3d
-1.4-0.6-0.8+0.1-1.4
4d
-1.2-0.7-0.5+0.0-1.2
5d
-1.6-1.9+0.3-0.6-1.0
1w
-0.5-2.4+1.9-0.5-0.0
15d
-0.3-3.3+3.0-2.5+2.3
1m
+0.9-3.5+4.4-3.6+4.5
2m
-7.4-4.5-2.9-6.4-1.0
3m
-12.8-6.3-6.5-7.8-5.0
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 19Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 results (ended Sept 30, 2025). Consolidated revenue rose 6.7% YoY to Rs 7,977M for H1; Q2 revenue at Rs 4,448M grew 6.5%. H1 PAT grew 9% to Rs 1,294M, but Q2 PAT slipped 4.3% YoY to Rs 756M. Company acquired Prashanthi Hospital (Rs 326M) and Pratiksha Hospital (Rs 1,710M). Auditor S.R. Batliboi issued unmodified review. Mr. Abrarali Dalal appointed CEO effective Jan 20, 2026.

Likely market impact

Modest revenue growth, Q2 PAT slightly down. Hospital acquisitions to widen footprint. New CEO joins Jan 2026.